Anthem Inc (ANTM)-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014162)
◆英語タイトル:Anthem Inc (ANTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014162
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:74
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Anthem Inc (Anthem), formerly WellPoint Inc, is a health benefits company. It offers several managed healthcare related products and related administrative services. It also provides various specialty and insurance products and services including radiology benefit management, dental, life and disability insurance benefits, and analytics-driven personal health care. Anthem offers its products and services to large and small employer, federal government, Medicaid and Medicare markets, and individuals. Its various types of medical membership customers include Local Group, Individual, National Accounts, BlueCard, Medicare, Medicaid, and Federal Employee Program (FEP). The company is an independent licensee of the Blue Cross and Blue Shield Association (BCBSA), and has license for insurance operations in all the 50 states of the US. Anthem is headquartered in Indiana, the US.

Anthem Inc (ANTM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Anthem Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Anthem Inc, Medical Devices Deals, 2011 to YTD 2017 10
Anthem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Anthem Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Linkwell Health Raises US$11 Million In Series C Financing 12
Private Equity 13
LLR Partners, WellPoint And Stanley B. Blaylock Invests In Physicians Immediate Care 13
Partnerships 14
Anthem, HealthCore and Boehringer Ingelheim Enter into Agreement 14
Eli Lilly Enters into Research Agreement with Anthem and HealthCore 15
Debt Offering 16
WellPoint Completes Private Placement Of Debentures Due 2042 For US$1.5 Billion 16
WellPoint Completes Public Offering Of Notes Due 2015 For US$625 Million 18
WellPoint Completes Public Offering Of Notes Due 2018 For US$625 Million 20
WellPoint Completes Public Offering Of Notes Due 2023 For US$1 Billion 22
WellPoint Completes Public Offering Of Notes Due 2043 For US$1 Billion 24
WellPoint Completes Public Offering Of Senior Notes Due 2022 For US$850 Million 26
WellPoint Completes Public Offering Of Senior Notes Due 2042 For US$900 Million 27
Acquisition 28
Anthem Acquires Simply Healthcare 28
WellPoint Completes Acquisition Of Amerigroup For US$4.9 Billion 29
Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 31
Amerigroup Acquires Health Plus From Lutheran Medical Center For US$85 Million 32
WellPoint Completes Acquisition Of CareMore Health Plan From CCMP Capital Advisors 34
Anthem Inc – Key Competitors 36
Anthem Inc – Key Employees 37
Anthem Inc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 41
Financial Announcements 41
Oct 25, 2017: Anthem Reports Third Quarter 2017 Results 41
Jul 26, 2017: Anthem Reports Second Quarter 2017 Results 44
Apr 26, 2017: Anthem Reports First Quarter 2017 Results 46
Feb 01, 2017: Anthem Reports Fourth Quarter and Full Year 2016 Results 49
Nov 02, 2016: Anthem Reports Third Quarter 2016 Results 50
Jul 27, 2016: Anthem Reports Second Quarter 2016 Results 52
Apr 27, 2016: Anthem Reports First Quarter 2016 Results 54
Jan 27, 2016: Anthem Reports Fourth Quarter and Full Year 2015 Results 57
Corporate Communications 59
Nov 16, 2017: Anthem Names Greg Poulakos President of Anthem Life & Disability Business 59
Nov 06, 2017: Anthem Announces Key Management Changes 60
Aug 30, 2017: Anthem Names Tomas Orozco President of Medicare East Region 61
Aug 24, 2017: Anthem Names Jacquelyn H. Wolf as Executive Vice President, Chief Human Resources Officer 62
Nov 16, 2016: Anthem Names Scott Towers as President of Dental Business 63
May 04, 2016: Anthem Names John Gallina Chief Financial Officer 64
Feb 25, 2016: Anthem Dr. Craig Samitt Appointed to NCQA Board of Directors 65
Legal and Regulatory 66
Apr 28, 2017: Anthem Responds to U.S. Court of Appeals Decision on Acquisition of Cigna 66
Feb 09, 2017: Anthem Responds to U.S. District Court’s Decision on Acquisition of Cigna 67
Mar 21, 2016: Anthem Files Suit against Pharmacy Benefit Manager to Recover Damages for Pricing and Operations Issues 68
Government and Public Interest 69
Sep 07, 2017: Anthem: Certain Patients with Type 2 Diabetes Less Likely to Suffer Heart Failure While Taking New Class of Antidiabetic Drug 69
Aug 23, 2017: Anthem Reaches Goal Two Years Early for Health Plans to Reduce Opioids Filled at Pharmacy by 30 Percent 70
Product News 71
Nov 08, 2017: Anthem Health Plans Play Major Role in Trial to Determine Best Aspirin Dose to Prevent Heart Attacks and Strokes 71
Other Significant Developments 72
Oct 18, 2017: Anthem Launches IngenioRx, New Pharmacy Benefits Manager 72
May 25, 2016: Pharmacy Programs That Tackle Inappropriate Opioid and Rx Drug Use Can Improve Drug Safety and Health Care Quality 73
Appendix 74
Methodology 74
About GlobalData 74
Contact Us 74
Disclaimer 74

List of Tables
Anthem Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Anthem Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Anthem Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Anthem Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Anthem Inc, Medical Devices Deals, 2011 to YTD 2017 10
Anthem Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Linkwell Health Raises US$11 Million In Series C Financing 12
LLR Partners, WellPoint And Stanley B. Blaylock Invests In Physicians Immediate Care 13
Anthem, HealthCore and Boehringer Ingelheim Enter into Agreement 14
Eli Lilly Enters into Research Agreement with Anthem and HealthCore 15
WellPoint Completes Private Placement Of Debentures Due 2042 For US$1.5 Billion 16
WellPoint Completes Public Offering Of Notes Due 2015 For US$625 Million 18
WellPoint Completes Public Offering Of Notes Due 2018 For US$625 Million 20
WellPoint Completes Public Offering Of Notes Due 2023 For US$1 Billion 22
WellPoint Completes Public Offering Of Notes Due 2043 For US$1 Billion 24
WellPoint Completes Public Offering Of Senior Notes Due 2022 For US$850 Million 26
WellPoint Completes Public Offering Of Senior Notes Due 2042 For US$900 Million 27
Anthem Acquires Simply Healthcare 28
WellPoint Completes Acquisition Of Amerigroup For US$4.9 Billion 29
Inova Health Completes Acquisition Of Amerigroup Virginia, Healthcare Company 31
Amerigroup Acquires Health Plus From Lutheran Medical Center For US$85 Million 32
WellPoint Completes Acquisition Of CareMore Health Plan From CCMP Capital Advisors 34
Anthem Inc, Key Competitors 36
Anthem Inc, Key Employees 37
Anthem Inc, Subsidiaries 38

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Anthem Inc (ANTM)-製薬・医療分野:企業M&A・提携分析(Anthem Inc (ANTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆